GlassScriptPhysician profile
Edward Gregory Soltesz
NPI 1629015730
$835,037.92
in general payments reported to CMS, 2019-2025
17 companies · $112K in 2025
The $112K reported for 2025 was more than what 99% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $106K · 2020: $76K · 2021: $84K · 2022: $125K · 2023: $154K · 2024: $178K · 2025: $112K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $173K · Honoraria: $132K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $57K · Travel and Lodging: $44K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $27K · Food and Beverage: $11K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $173,362.50 |
| Honoraria | $131,600.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $57,000.00 |
| Travel and Lodging | $44,244.67 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $27,187.50 |
| Food and Beverage | $10,587.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $375,868.27 | 2019-2025 | Impella |
| Abbott Laboratories | $236,469.39 | 2019-2025 | Epic, Mitraclip, Thoratec Heartmate 3 Lvas Implant Kit |
| Atricure, INC. | $181,936.16 | 2019-2025 | Epi-Sense Guided Coagulation System With Visitrax, Synergy Ablation System, Atriclip Laa Exclusion System |
| Edwards Lifesciences Corporation | $25,767.42 | 2019-2023 | |
| Dilon Technologies, INC. | $13,691.42 | 2024-2025 | Hemoblast Bellows |
| Jace Medical LLC | $498.60 | 2019-2020 | |
| Corcym INC | $199.59 | 2022-2023 | Perceval |
| Biom'Up Sa | $134.35 | 2019 | |
| Medtronic, INC. | $94.36 | 2024-2025 | Avalus, Mosaic |
| Medtronic Vascular, INC. | $89.62 | 2019-2020 | |
| Bolton Medical INC | $74.73 | 2019 | |
| Baxter Healthcare | $62.57 | 2024-2025 | Tisseel, Preveleak |
| Supreme Orthopedic Systems, LLC | $42.29 | 2025 | |
| Nexus Medical Technologies LLC | $33.38 | 2025 | |
| Livanova USA, INC. | $32.47 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $26.92 | 2024 | Na |
| Ethicon US, LLC | $16.38 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Soltesz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.